Luneri

Zinc clinical brief

Zinc

Dossier live

Compound

CompoundDossier-backed

Publication state

Dossier live

Published from structured dossier data. Authored scoring and decision-tool promotion can be layered in later.

What it is for

Metabolic support in type 2 diabetes / insulin resistance

The clearest current human use case based on dose, outcomes, and clinical coverage.

What moves

Highest-signal biomarkers

Human linked

HOMA-IR

Glycemic control

Decrease

Grade A

HbA1c

Glycemic control

Decrease

Grade A

Fasting glucose

Glycemic control

Decrease

Grade A

Research signal

Top caution

Tetracyclines (tetracycline, doxycycline, minocycline)

Subtherapeutic antibiotic levels may result in treatment failure for bacterial infections.

Dossier status

Dossier live

Published from dossier data; authored scoring and decision-tool promotion can be layered in later.

Meta-analyses

328

Pooled human evidence

RCTs

1019

Randomized clinical trials

Tracked studies

9671

Studies currently mapped to this dossier

Clinical memoDossier-backed

Executive summary

Immediate brief

Zinc is a compound with its clearest current use in Metabolic support in type 2 diabetes / insulin resistance.

This live dossier is anchored by 9671 tracked studies, 328 meta-analyses, 1019 RCTs and the clearest tracked movement in HOMA-IR, HbA1c, Fasting glucose.

Subtherapeutic antibiotic levels may result in treatment failure for bacterial infections. Subtherapeutic antibiotic levels may result in treatment failure for bacterial infections. Zinc supplementation is adjunctive in T2D management in populations with inadequate glycemic control and possible zinc deficiency; not a standalone glucose-lowering intervention; baseline zinc status and glycemic control should guide prescription

Anchor decision

Metabolic support in type 2 diabetes / insulin resistance

Best current human use case

Publication

Dossier live

Published from structured dossier data; authored scoring and decision-tool promotion can be layered in later.

How to use this brief

1. Orient

Use the overview tab to understand mechanism, safety, scope, and where the current evidence still has blind spots.

2. Pressure-test

Move into evidence and biomarkers once the memo already makes sense, so the tables confirm or challenge the narrative rather than replace it.

3. Operationalize

Finish with dosing and PGx when the compound still looks useful and you are deciding whether it belongs in a real protocol.

ZincDossier livePrimary useMetabolic support in type 2 diabetes / insulin resistance

CautionTetracyclines (tetracycline, doxycycline, minocycline)

Major warning

Pregnancy (high-dose supplementation >40 mg/d elemental zinc)

Zinc supplementation is adjunctive in T2D management in populations with inadequate glycemic control and possible zinc deficiency; not a standalone glucose-lowering intervention; baseline zinc status and glycemic control should guide prescription

Overview

Clinical posture

Start with mechanism and safety, then move into scope, synergies, and the open questions that still matter before going deeper into tables.

Primary signal

Mechanism summary

Read this as the shortest defensible explanation for why the compound belongs in the conversation at all.

Pancreatic beta-cell zinc co-crystallization with insulin hexamers; zinc required for regulated insulin granule storage and secretion via ZnT8 (SLC30A8) transporter; zinc deficiency impairs insulin processing and secretion

Inhibition of NF-kB signaling via A20 zinc finger protein induction and IkB kinase suppression; reduces transcription of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha; zinc-dependent peroxisome proliferator-activated receptor (PPAR) activation further attenuates inflammatory gene expression

Structural cofactor of Cu/Zn-superoxide dismutase (SOD1); induces metallothionein synthesis via MTF-1 zinc finger transcription factor, scavenging ROS and sequestering cadmium/lead; zinc activates NRF2 via Keap1 modification, upregulating HO-1, NQO1, and glutathione synthesis enzymes (GCLC, GCLM)

Required cofactor for type I and type II iodothyronine deiodinases; zinc deficiency impairs T4→T3 peripheral conversion; thyroid hormone receptors contain zinc finger DNA-binding domains requiring zinc for transcriptional activity

Co-primary

Safety summary

These are the reasons this compound can still break trust if the protocol fit is otherwise attractive.

Subtherapeutic antibiotic levels may result in treatment failure for bacterial infections.

Pregnancy (high-dose supplementation >40 mg/d elemental zinc)

Supporting context

Evidence scope

Read these caveats before assuming the effect sizes generalize cleanly across every population or use case.

Evidence scope

Review

Generalizability

Review

Clinical utility of zinc supplementation for metabolic outcomes in Western populations with adequate dietary zinc may be substantially lower than pooled MA estimates suggest; assessment of zinc status before supplementation is important

Evidence scope

Review

Anti-inflammatory effects are meaningful adjunctive benefits in chronic low-grade inflammation contexts (T2D, MetS, CKD) but may not be clinically significant in healthy individuals; baseline CRP elevation may be a useful predictor of anti-inflammatory response

Evidence scope

Review

Zinc supplementation for testosterone support is only clinically relevant in males with documented or suspected zinc deficiency (low serum zinc, high phytate diet, malabsorption, CKD); not appropriate as general testosterone optimization in zinc-replete males

Synergies

Potential pairing logic is useful only when it adds a cleaner decision path, not when it becomes an excuse to stack indiscriminately.

Zinc + vitamin_c + vitamin_e + lutein + zeaxanthin + copper

ADeclared

This is the AREDS2 formula - the most rigorously tested nutraceutical combination in all of ophthalmology.

Zinc + magnesium

BDeclared

Evidence base is limited to a single small RCT (n=30).

Research unknowns

These are the open questions that still keep the compound from reading like a closed case.

What is the precise mechanism by which zinc modulates NMDA receptor function in the human CNS, and does oral zinc supplementation achieve sufficient CNS zinc concentrations to meaningfully alter glutamatergic neurotransmission?

Do metabolic benefits of zinc supplementation (glycemic, lipid, inflammatory) persist in Western zinc-replete populations, or are observed effects entirely driven by deficiency correction in Middle Eastern/Asian cohorts?

What are the long-term (>2 years) safety outcomes of zinc supplementation in children, particularly regarding copper status, iron status, and growth trajectories?

What is the optimal copper co-supplementation dose per mg of elemental zinc to prevent copper depletion, given that attia_2022 showed 2 mg copper was insufficient to offset 40 mg zinc?